Glickman; Laura Hix

Patent Applications and Registrations

Patent applications and USPTO patent grants for Glickman; Laura Hix.The latest application filed is for "engineered immunostimulatory bacterial strains and uses thereof".

Company Profile

11.7.18

Glickman; Laura Hix - Oakland CA
Glickman; Laura Hix - Berkeley CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Engineered Immunostimulatory Bacterial Strains And Uses Thereof App 20220280577 - THANOS; Christopher D. ; et al.	2022-09-08
Immunostimulatory Bacteria Delivery Platforms And Their Use For Delivery Of Therapeutic Products App 20220154136 - THANOS; Christopher D. ; et al.	2022-05-19
Immunostimulatory Bacteria Engineered To Colonize Tumors, Tumor-resident Immune Cells, And The Tumor Microenvironment App 20220135980 - THANOS; Christopher D. ; et al.	2022-05-05
Immunostimulatory Bacteria-based Vaccines, Therapeutics, And Rna Delivery Platforms App 20220119824 - GLICKMAN; Laura Hix ; et al.	2022-04-21
Engineered Immunostimulatory Bacterial Strains And Uses Thereof App 20220112501 - Thanos; Christopher D. ; et al.	2022-04-14
Engineered immunostimulatory bacterial strains and uses thereof Grant 11,242,528 - Thanos , et al. February 8, 2	2022-02-08
Engineered Immunostimulatory Bacterial Strains And Uses Thereof App 20220017904 - Thanos; Christopher D. ; et al.	2022-01-20
Engineered immunostimulatory bacterial strains and uses thereof Grant 11,168,326 - Thanos , et al. November 9, 2	2021-11-09
Compositions and methods for activating "stimulator of interferon gene"13 dependent signalling Grant 11,040,053 - Katibah , et al. June 22, 2	2021-06-22
Engineered Immunostimulatory Bacterial Strains And Uses Thereof App 20210030813 - Thanos; Christopher D. ; et al.	2021-02-04
Compositions and methods for activating "stimulator of interferon gene"-dependent signalling Grant 10,906,930 - Katibah , et al. February 2, 2	2021-02-02
Immunostimulatory Bacteria Engineered To Colonize Tumors, Tumor-resident Immune Cells, And The Tumor Microenvironment App 20200270613 - THANOS; Christopher D. ; et al.	2020-08-27
Engineered Immunostimulatory Bacterial Strains And Uses Thereof App 20200215123 - Thanos; Christopher D. ; et al.	2020-07-09
Compositions And Methods For Activating "stimulator Of Interferon Gene" - Dependent Signalling App 20200179431 - Katibah; George Edwin ; et al.	2020-06-11
Engineered Immunostimulatory Bacterial Strains And Uses Thereof App 20200071702 - THANOS; Christopher D. ; et al.	2020-03-05
Compositions and methods for activating "stimulator of interferon gene"--dependent signalling Grant 10,449,211 - Katibah , et al. Oc	2019-10-22
Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use Grant 10,414,789 - Dubensky, Jr. , et al. Sept	2019-09-17
Compositions And Methods For Activating "stimulator Of Interferon Gene"-dependent Signalling App 20190062365 - KATIBAH; George Edwin ; et al.	2019-02-28
Engineered Immunostimulatory Bacterial Strains And Uses Thereof App 20190017050 - Thanos; Christopher D. ; et al.	2019-01-17
Compositions And Methods For Activating "stimulator Of Interferon Gene" - Dependent Signalling App 20180064745 - Katibah; George Edwin ; et al.	2018-03-08
Use Of Sting Agonist As Cancer Treatment App 20180028553 - Gajewski; Thomas F. ; et al.	2018-02-01
Compositions Comprising Cyclic Purine Dinucleotides Having Defined Stereochemistries And Methods For Their Preparation And Use App 20170283454 - Dubensky, JR.; Thomas W. ; et al.	2017-10-05
Compositions comprising cyclic purine dinucleotides having defined stereochemistries and methods for their preparation and use Grant 9,695,212 - Dubensky, Jr. , et al. July 4, 2	2017-07-04
Use Of Sting Agonist As Cancer Treatment App 20160287623 - Gajewski; Thomas F. ; et al.	2016-10-06
Compositions Comprising Cyclic Purine Dinucleotides Having Defined Stereochemistries And Methods For Their Preparation And Use App 20140205653 - Dubensky, JR.; Thomas W. ; et al.	2014-07-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.